Memamed (Memantine Hydrochloride)

Memantine hydrochloride works by blocking the NMDA receptor’s ion channel in a non‑competitive manner. This reduces excessive calcium entry caused by prolonged glutamate activity, protecting neurons from excitotoxic damage that contributes to cognitive decline in Alzheimer’s disease.

The appropriate dose of Memamed is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for memantine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Memamed, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Memamed (memantine) belongs to the NMDA receptor antagonist class, differing from cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors increase acetylcholine levels, memantine reduces glutamate‑mediated excitotoxicity. Both classes may be used together in some patients to target different disease pathways.

Memamed should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Memamed is taken orally, usually once daily after a meal to improve tolerability. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include seizures, severe allergic reactions such as rash or angioedema, hallucinations or psychosis, suicidal thoughts, hepatotoxicity, and cardiac arrhythmias. Patients should be monitored closely for any of these events and seek immediate medical attention if they occur.

Memamed is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists, as the risk of adverse effects may be heightened.